EF
TARO

Empirical Finance’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Empirical Finance’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,913
Closed -$1.39M – 422
2021
Q1 		$1.39M Hold
18,913
– – 0.24% 107
2020
Q4 		$1.39M Hold
18,913
– – 0.24% 107
2020
Q3 		$1.04M Buy
18,913
+164
+0.9% +$10.2K 0.22% 118
2020
Q2 		$1.25M Buy
18,749
+550
+3% +$36.9K 0.32% 89
2020
Q1 		$1.11M Buy
18,199
+8,523
+88% +$632K 0.35% 79
2019
Q4 		$851K Buy
9,676
+115
+1% +$9.7K 0.21% 112
2019
Q3 		$721K Hold
9,561
– – 0.2% 99
2019
Q2 		$817K Buy
9,561
+50
+0.5% +$4.95K 0.22% 89
2019
Q1 		$1.03M Sell
9,511
-4,263
-31% -$424K 0.26% 76
2018
Q4 		$1.17M Hold
13,774
– – 0.35% 69
2018
Q3 		$1.35M Hold
13,774
– – 0.34% 74
2018
Q2 		$1.59M Buy
13,774
+4,263
+45% +$468K 0.4% 45
2018
Q1 		$1.03M Sell
9,511
-557
-6% -$56.4K 0.26% 76
2017
Q4 		$1.05M Sell
10,068
-10,521
-51% -$1.16M 0.35% 80
2017
Q3 		$2.32M Buy
20,589
+10,257
+99% +$1.12M 0.8% 28
2017
Q2 		$1.16M Buy
10,332
+23
+0.2% +$2.6K 0.45% 65
2017
Q1 		$1.2M Buy
10,309
+10,027
+3,556% +$1.11M 0.56% 39
2016
Q4 		$30K Buy
+282
New +$29.5K 0.02% 147

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Empirical Finance's TARO Position: Q2 2021 in Review

Empirical Finance sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2021, closing a stake of 18,913 shares — an estimated $1.39M sold.

Empirical Finance first reported a position in TARO in Q4 2016 and held it in 18 quarters. The position peaked at $2.32M in Q3 2017. 76 funds tracked by Wall St. Rank hold TARO as of Q2 2021.

  • Empirical Finance reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2021 after selling out during the quarter.
  • Empirical Finance sold 18,913 Taro Pharmaceutical Industries Ltd. shares in Q2 2021, an estimated $1.39M.
  • Empirical Finance first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2016 and held it in 18 quarters.
  • Empirical Finance's Taro Pharmaceutical Industries Ltd. position peaked at $2.32M in Q3 2017.
  • 76 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2021.

Based on Empirical Finance's 13F filing for Q2 2021, filed 4 Aug 2021.